Abstract
e15599Background: Circulating tumor DNA (ctDNA) is a promising marker for monitoring tumor burden and therapy response in metastatic colorectal cancer (mCRC). The AIO KRK 0207 trial investigated di...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
